Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Thyroid Neoplasms 1Neoplasm Metastasis 1

Interventions

Specimen Handling 195Magnetic Resonance Spectroscopy 154pembrolizumab 152Carboplatin 115Biopsy 110Cyclophosphamide 100Cisplatin 88Paclitaxel 80Gemcitabine 72Bevacizumab 70fludarabine 61Nivolumab 60Radiotherapy 52Fluorouracil 52Capecitabine 49Dexamethasone 48Pemetrexed 46Rituximab 44Oxaliplatin 44Docetaxel 44Leucovorin 43atezolizumab 42Doxorubicin 42venetoclax 39durvalumab 39Standard of Care 34Prednisone 34Temozolomide 33Radiation 33Cetuximab 32

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Iodine-124 × 30 days × Clear all
NCT03841617 2026-06-05

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
30 enrolled
Head & Neck

Neoplasm Metastasis, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡